Abstract Background and Aim Chronic hepatitis C virus (HCV) infection is one of the leading
causes of cirrhosis and hepatocellular carcinoma worldwide. It is highly prevalent among …

Despite new Hepatitis C virus (HCV) therapeutic advances, challenges remain for HCV
testing and linking patients to care. A point-of-care (POC) HCV antibody testing strategy was …

Hepatitis C virus (HCV) surveillance is a critical component of a comprehensive strategy to
prevent and control HCV infection and HCV‐related chronic liver disease. The emergency …

Background Periodic surveillance of the hepatitis C virus (HCV) care cascade is important
for tracking progress toward HCV elimination goals, identifying gaps in care, and prioritizing …

Objective. People who inject drugs (PWID) are at increased risk for hepatitis C virus (HCV)
infection. We examined HCV testing outcomes among PWID through CDC's Hepatitis …

Background Hepatitis C elimination will require widespread access to treatment and
responses at the health-service level to increase testing among populations at risk. We …

Objective To evaluate the feasibility of testing and treating people who inject drugs at a
supervised injecting facility for hepatitis C virus (HCV) infection. Design Retrospective cohort …

Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist
today, increasing the feasibility of disease elimination. However, large healthcare systems …

Abstract Background & Aims New models of HCV care are needed to reach people who
inject drugs (PWID). The primary aim was to evaluate HCV treatment uptake among HCV …

Hepatitis C virus (HCV) screening is recommended for patients at risk and/or born during
1945–1965, but screening gaps persist. This new program screens target populations and …